Genomic Vision: 2021 Annual Results : vimarsana.com

Revenue from activity up 9% in 2021, to €1.4 million Good control over current operating expenses (-5.5%) Financial resources offering visibility through to end-May 2022 Implementation

Related Keywords

Paris , France General , France , Bagneux , Bracknor Negma , Dominique Remy Renou , Strategic Communications , Company Paris , Research Tax Credit , Research Development , Euronext , Sales Marketing , General Administrative , Extraordinary General Meeting , Chief Financial Officer , Genomic Vision , Thursday May , Supervisory Board , Genomic , Vision , 021 , Nnual , Results ,